Publications by authors named "Jialei Qi"

Claim this Profile
A
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors.
Jialei Qi, Sascha Endres, Deyan Yordanov Yosifov, Eugen Tausch, Rashmi Priyadharshini Dheenadayalan

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.
Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, Sascha Endres, Philipp M Roessner, Jialei Qi

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of miR-338 is associated with poor prognosis in acute myeloid leukemia undergoing chemotherapy.
Lin Fu, Jialei Qi, Xiang Gao, Ninghan Zhang, Huihui Zhang

J Cell Physiol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia.
Jialei Qi, Xiang Gao, Xiaomin Zhong, Ninghan Zhang, Rong Wang, Qingyun Wu

Biomed Pharmacother· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of realgar (AsS) on degradation of PML-RARA harboring acquired arsenic-resistance mutations.
Mingshan Niu, Yangling Shen, Jialei Qi, Xuejiao Liu, Wei Sang, Qingyun Wu

Ann Hematol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis